Mazaheri M R, Hamblin A S, Zuckerman A J
J Med Virol. 1977;1(3):209-17. doi: 10.1002/jmv.1890010308.
It has been reported that dialysable leucocyte extract preparations, thought to contain transfer factor, may be used therapeutically for the treatment of a variety of immunodeficiency syndromes. Clinical and laboratory studies have suggested that such preparations, in addition to transferring specific cellular immunity may also contain non-specific adjuvant activities. Attempts at immunotherapy of viral infections are described against a background of current research on the biological and biochemical properties of leucocyte dialysates.
据报道，被认为含有转移因子的可透析白细胞提取物制剂可用于多种免疫缺陷综合征的治疗。临床和实验室研究表明，此类制剂除了转移特异性细胞免疫外，还可能含有非特异性佐剂活性。本文在白细胞透析液生物学和生化特性当前研究的背景下，描述了针对病毒感染的免疫治疗尝试。
